Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 5/20 | 0.67 |
| ▸ | PIK3CB | P42338 | 12/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.45 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.42 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.39 |
| ▸ | RAF1 | P04049 | 1/20 | 0.38 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124342 | 0.91 | PIK3CD (0.80) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL16309694 | 0.89 | PIK3CB (0.55) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL16309716 | 0.88 | PIK3CD (0.65) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15029429 | 0.87 | PIK3CD (0.53) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL16308262 | 0.86 | PIK3CD (0.49) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15009578 | 0.86 | PIK3CB (0.48) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15009575 | 0.86 | PIK3CB (0.48) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15008843 | 0.85 | PIK3CB (0.50) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15008839 | 0.85 | PIK3CB (0.50) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG | |
| SCHEMBL15029321 | 0.85 | PIK3CD (0.71) | PIK3CDPIK3CBPIK3CAPIK3R1PIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912180-B2 | Heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2014-12-16 | — | — | US | disclosed |